Article

jdsupra.comjdsupra.com on 2017-03-30 20:23

FDA Approves Genentech’s Ocrevus (ocrelizumab)

FDA announced today that it has approved Genentech’s Ocrevus® (ocrelizumab) for the treatment of adults with relapsing forms of multiple sclerosis and ...

Related news